Shanghai - Delayed Quote CNY

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS)

7.42
+0.02
+(0.27%)
As of 2:28:41 PM GMT+8. Market Open.
Loading Chart for 600866.SS
  • Previous Close 7.40
  • Open 7.37
  • Bid 7.43 x --
  • Ask 7.44 x --
  • Day's Range 7.37 - 7.47
  • 52 Week Range 4.76 - 7.94
  • Volume 18,030,056
  • Avg. Volume 33,060,335
  • Market Cap (intraday) 12.328B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 10.60
  • EPS (TTM) 0.70
  • Earnings Date --
  • Forward Dividend & Yield 0.38 (5.14%)
  • Ex-Dividend Date Jun 17, 2024
  • 1y Target Est --

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned and salted meat, ham, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. Star Lake Bioscience Co., Inc.Zhaoqing Guangdong was founded in 1964 and is based in Zhaoqing, China.

www.starlake.com.cn

9,293

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600866.SS

View More

Performance Overview: 600866.SS

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600866.SS
14.68%
SSE Composite Index (000001.SS)
0.02%

1-Year Return

600866.SS
21.59%
SSE Composite Index (000001.SS)
8.39%

3-Year Return

600866.SS
31.53%
SSE Composite Index (000001.SS)
6.42%

5-Year Return

600866.SS
74.21%
SSE Composite Index (000001.SS)
17.48%

Compare To: 600866.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600866.SS

View More

Valuation Measures

Annual
As of 5/29/2025
  • Market Cap

    12.29B

  • Enterprise Value

    13.24B

  • Trailing P/E

    10.55

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.72

  • Price/Book (mrq)

    1.46

  • Enterprise Value/Revenue

    0.77

  • Enterprise Value/EBITDA

    8.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.79%

  • Return on Assets (ttm)

    7.51%

  • Return on Equity (ttm)

    14.22%

  • Revenue (ttm)

    17.17B

  • Net Income Avi to Common (ttm)

    1.17B

  • Diluted EPS (ttm)

    0.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.08B

  • Total Debt/Equity (mrq)

    47.05%

  • Levered Free Cash Flow (ttm)

    2.82B

Research Analysis: 600866.SS

View More

Company Insights: 600866.SS

Research Reports: 600866.SS

View More

People Also Watch